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Abstract
Background—α-Klotho (αKl) regulates mineral metabolism such as calcium ion (Ca2+) and
inorganic phosphate (Pi) in circulation. Defects in mice result in clinical features resembling
disorders found in human aging. Although the importance of transmembrane-type αKl has been
Correspondence and requests for reprint should be addressed to Yo-ichi Nabeshima, M.D. & Ph.D. nabemr@lmls.med.kyoto-u.ac.jp
Phone: +81-75-753-4422, FAX: +81-75-753-4686 Yuji Yamazaki, M.S. yuji.yamazaki@kyowa-kirin.co.jp Phone: +81-42-725-2555,
FAX: +81-42-726-8330.
Each author's; Yuji Yamazaki: yuji.yamazaki@kyowa-kirin.co.jp Akihiro Imura: imura@lmls.med.kyoto-u.ac.jp Itaru Urakawa:
itaru.urakawa@kyowa-kirin.co.jp Takashi Shimada: takashi.shimada@kyowa-kirin.co.jp Junko Murakami: junko.murakami@kyowa-
kirin.co.jp Yukiko Aono: yukiko.aono@kyowa-kirin.co.jp Hisashi Hasegawa: hisashi.hasegawa@kyowa-kirin.co.jp Takeyoshi
Yamashita: takeyoshi.yamashita@kyowa-kirin.co.jp Kimihiko Nakatani: nkimihik@nmu-gw.naramed-u.ac.jp Yoshihiko Saito:
yssaito@naramed-u.ac.jp Nozomi Okamoto: onozomi@naramed-u.ac.jp Norio Kurumatani: knorio@naramed-u.ac.jp Noriyuki
Namba: nnamba@ped.med.osaka-u.ac.jp Taichi Kitaoka: tkitaoka@ped.med.osaka-u.ac.jp Keiichi Ozono: keioz@ped.med.osaka-
u.ac.jp Tomoyuki Sakai: tomoyuki_sakai@tmhp.jp Hiroshi Hataya: hiroshi_hataya@tmhp.jp Shoji Ichikawa: ichikawa@iupui.edu
Erik A. Imel: eimel@iupui.edu Michael J. Econs: mecons@iupui.edu Yo-ichi Nabeshima: nabemr@lmls.med.kyoto-u.ac.jp
NIH Public Access
Author Manuscript
Biochem Biophys Res Commun. Author manuscript; available in PMC 2014 August 12.
Published in final edited form as:













demonstrated, less is known regarding the physiological importance of soluble-type αKl (sαKl) in
circulation.
Objectives—The aims of this study were: 1) to establish a sandwich ELISA system enabling
detection of circulating serum sαKl, and 2) to determine reference values for sαKl serum levels
and relationship to indices of renal function, mineral metabolism, age and sex in healthy subjects.
Results—We successively developed an ELISA to measure serum sαKl in healthy volunteers
(n=142, males 66) of ages (61.1 ± 18.5 yr). The levels (mean ± SD) in these healthy control adults
were as follows: total calcium (Ca; 9.46 ± 0.41 mg/dL), Pi (3.63 ± 0.51 mg/dL), Blood urea
nitrogen (BUN; 15.7 ± 4.3 mg/dL), creatinine (Cre; 0.69 ± 0.14 mg/dL), 1,25 dihydroxyvitamin D
(1,25(OH)2D; 54.8 ± 17.7 pg/mL), intact parathyroid hormone (iPTH; 49.2 ± 20.6 pg/mL),
calcitonin (26.0 ± 12.3 pg/mL) and intact Fibroblast growth factor (FGF23; 43.8 ± 17.6 pg/mL).
Serum levels of sαKl ranged from 239 to 1266 pg/mL (mean ± SD; 562 ± 146 pg/mL) in normal
adults. Although sαKl levels were not modified by gender or indices of mineral metabolism, sαKl
levels were inversely related to Cre and age. However, sαKl levels in normal children (n=39,
males 23, mean ± SD; 7.1 ± 4.8 years) were significantly higher (mean ± SD; 952 ± 282 pg/mL)
than those in adults (mean ± SD; 562 ± 146, P<0.001). A multivariate linear regression analysis
including children and adults in this study demonstrated that sαKl correlated negatively with age
and Ca, and positively with Pi. Finally, we measured a serum sαKl from a patient with severe
tumoral calcinosis derived from a homozygous missense mutation of α-klotho gene. In this
patient, sαKl level was notably lower than those of age matched controls.
Conclusion—We established a detection system to measure human serum sαKl for the first
time. Age, Ca and Pi seem to influence serum sαKl levels in a normal population. This detection
system should be an excellent tool for investigating sαKl functions in mineral metabolism.
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Introduction
α-kl gene encodes a type I membrane protein with expression restricted to parathyroid
glands, the choroid plexus and the kidney [1-4]. αKl binds to Na+,K+-ATPase to regulate
PTH secretion and is involved in transepitherial calcium concentration. In response to
altered extra-cellular calcium concentrations, αKl is rapidly translocated from endosomal
organella to the plasma membrane together with Na+,K+-ATPase and simultaneously the
extracellular domain of αKl is cleaved and secreted into the blood circulation and
cerebrospinal fluid (CSF) [5,6]. The increased Na+ gradient produced by elevated Na+,K+-
ATPase activity drives PTH secretion in parathyroid glands and transepithelial transport of
calcium in the kidney and choroid plexus [5]. Accordingly, it is assumed that αKl levels in
the serum and CSF mirror the molecular actions of the cellular form of αKl in these tissues.
αKl also binds to fibroblast growth factor 23 (FGF23), which was discovered in studies of
autosomal dominant hypophosphatemic rickets (ADHR) [7] and later tumor-induced
osteomalacia (TIO) [8, 9]. FGF23 (i) is produced and secreted from bone in response to
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serum levels of phosphorus and 1,25(OH)2D [10-12], (ii) binds to FGF receptor1 (FGFR1),
both suppressing 1α-hydroxylase (CYP27B1) expression and stimulating 24-hydroxylase
(CYP24A1) expression in kidney [13,14], and (iii) downregulates protein amounts of Na+
dependent-phosphate transporter (NaPi) IIa/c to the brush border membrane of proximal
tubules thus decreasing phosphate reabsorption [11].
αKl contributes to integrate mineral homeostasis. Consequently, disturbances of αKl
expression impair mineral metabolism via multiple mechanisms involving FGF23 signaling
[13, 14], PTH secretion and transepithelial calcium transport. Recently, a patient with
autosomal recessive hyperphosphatemic tumoral calcinosis shed new light on the impact of
αKl [15]. Mutation analysis revealed a missense mutation in αKl, and in vitro studies
indicated that αKl translocation to the plasma membrane was impaired [16]. Therefore,
analysis of serum αKl levels may lead to greater understanding of disorders of mineral
homeostasis.
In the present study, we developed an ELISA system to measure circulating sαKl
concentrations in serum from human subjects for the first time. We further analyzed and
compared sαKl levels of both healthy volunteers and a case with the α-klotho gene mutation
[16]. Finally, we discuss the potential utility in measuring serum αKl in clinical disorders.
Materials and methods
Plasmid construction
Human full length α-Klotho (fl-αKl; 1012 amino acids(a.a), RefSeq ID: NP_004786)-cDNA
and cDNA encoding extracellular domain of α-Klotho (sαKl; 1-979a.a.) were amplified
from total human kidney cDNAs by PCR and consequently cloned into pLP-CMVneo and
pLP-IRESneo, respectively, by In fusion PCR kit (Clonetech).
Cell culture
pLP-CMVneo-fl-αKl was transfected into HEK293 cells by the calcium-phosphate method.
pLP-IRESneo-sαKl was transfected into CHO cells, by the Lipofectamine method
(Invitrogen). Then, cells stably expressing either fl-αKl or sαKl were selected by G418 and
cloned by limiting dilution. HEK293 cells expressing fl-αKl were grown in DMEM
supplemented with 10% Fetal Calf Serum (FCS) and 1mg/mL of G418. CHO cells
expressing sαKl were grown in MEMα supplemented with 10% FCS and 2mg /mL of G418.
sαKl protein purification
Recombinant sαKl protein was purified from serum-free conditioned media (SFMII, Gibco)
of CHO cells stably expressing sαKl by a series of chromatographic steps employing Q
Sepharose XL, Butyl Sepharose FF, Heparin Sepharose HP, Q Sepharose HP, SP Sepharose
HP, DEAE Sepharose FF, Phenyl Sepharose HP, Q Sepharose HP, Lentil Lectin sepharose
4B, and DEAE Sepharose FF (All sepharoses were purchased from GE healthcare). The
concentration of purified sαKl protein was determined by absorbance at 280 nm.
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All mice were purchased from Charlesriver Inc. Japan and were maintained in SPF
conditions according to the institutional guidelines of Kyowa Hakko Kirin Co., Ltd.
Antibodies
Monoclonal anti-human α-Klotho antibodies were generated by immunizing B6D2F1 mice
once a week for 5 weeks with pLP-CMVneo-fl-αKl vector by TransIT in vivo gene delivery
system (Takara Bio). Hybridomas were obtained by fusing spleen cells and Sp2/o mouse
myeloma cells (ATCC ID CRL1581) with polyethylene glycol. Then, hybridomas producing
anti-α-Klotho antibody were selected by cell ELISA and flow cytometry analysis by using
HEK293 cells stably expressing fl-αKl. Finally, nine monoclonal antibodies were purified
with Protein G Sepharose 4FF (GE healthcare) and we next tested all pairs of antibodies
with high affinity against recombinant sαKL for sandwich ELISA by using conjugated
antibodies with biotin as detection antibodies. A pair of antibodies that have the highest
reactivity to sαKl protein were named 67G3 (IgG1, kappa) as a capture antibody and 91F1
(IgG1, kappa) as a detection antibody, respectively. Rabbit anti-human α-Klotho polyclonal
antibodies (N116 and C939) were generated by immunization of two different human α-
Klotho partial polypeptides from N-terminal region (PLQPATGDVASDSYNNVFRDT,
116-136a.a.) and C-terminal region (ASMKHYRKIIDSNGFPGPETLERFC, 939-963a.a.),
respectively.
Subjects
Healthy Asian volunteers (n=181, 89 males) between 0.1 and 88 years of age participated in
our study. Subjects had no known medical conditions. A patient with a missense mutation of
the α-klotho gene was described in a previous paper [16]. The study protocol was approved
by the ethics committee on human research at Kyoto University Graduate School of
Medicine, Tokyo Metropolitan Children's Medical Center, Osaka University Hospital, Nara
Medical University Hospital and Indiana University. Written informed consent was obtained
from subjects prior to enrollment. All subjects had normal serum Ca, Pi, 1,25(OH)2D, iPTH,
calcitonin, FGF23 levels and normal renal function as assessed by BUN and serum Cre
levels.
Measurement of serum parameters
Blood samples were drawn from a forearm vein in the morning after overnight fasting. Sera
were obtained by centrifugation and immediately stored at −30°C. Serum FGF23
concentrations were measured by a FGF23 kit (Kainos) which can only measure the intact
FGF23 [9]. Ca, Pi, BUN, Cre and Alb were measured at SRL Inc. Japan using standard
clinical methods. Serum levels of iPTH, calcitonin and 1,25(OH)2D were measured only in
adults (>20 years) at SRL Inc. because of limited serum quantity in children. The mean
values of age and serum biochemical tests from each group are shown in Table 1.
Immunoprecipitation and Western blot
500μL of sera from two healthy subjects and purified sαKl protein were incubated with resin
(NHS-activated Sepharose 4 FF; GE healthcare) conjugated with 67G3, 91F1 or isotype-
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matched control antibody (mouse IgG1) at 4°C for 2h. The specifically retained proteins on
the resin were solubilized by boiling in SDS-PAGE sample buffer with the reducing agent
and separated by SDS-PAGE. Following electrophoresis, proteins were transferred to PVDF
membrane and bound with the biotin labeled N116 or C939 antibodies followed by HRP-
conjugated streptavidin (DAKO). Protein bands were visualized by the ECL system (GE
healthcare)
ELISA procedure
Wells of microtiter plates were coated with 1 μg/mL of 67G3 monoclonal antibody in 100
μL of carbonate buffer (pH9.5) for 18h at 4 °C and then blocked with 1% BSA in PBS for
1h at 37°C. Samples (50μL) were premixed with dilution buffer (50μL; PBS, pH7.4,
containing 0.05% Tween20, 1% BSA, and 50μg /mL purified normal mouse IgG). The
mixtures were loaded and incubated for 1h at room temperature (RT), followed by the
addition of 100μL 91F1-Fab’ conjugated with HRP by using N-(6-
Maleimidocaproyloxy)succinimide (EMCS, Dojindo) in PBS for 30 min at RT, and the
reaction was visualized by the addition of 100μL of chromogenic substrate (TMB+, Dako)
for 30 min at RT. The reaction was stopped with 100μL of 1N H2SO4 and absorbance at
450nm was measured with a reduction at 570 nm using ELISA plate reader. Plates were
washed 6 times with washing buffer (PBS, pH7.4, containing 0.1% (v/v) Tween 20) after
each step. A standard curve was established by a serial dilution of recombinant sαKl.
Results
Establishment of anti-αKl mouse monoclonal antibodies for sandwich ELISA
To establish mouse monoclonal antibodies with strong affinity for human αKl protein, we
immunized mice with a human full-length αKl expressing vector and screened the resulting
hybridomas by measuring the binding affinities to human αKl expressing cells. Nine
antibodies which showed high and specific affinities to an extracellular domain of human
αKl protein were tested for compatibility as a capture antibody or detection antibody in
sandwich ELISA to detect sαKl protein. We finally selected a pair of antibodies (67G3 for a
capture antibody and 91F1 for a detection antibody). While these antibodies are not useful
for Western blot assays, both antibodies have a high affinity in immunoprecipitation to sαKl
protein as well as in Cell ELISA and Flow cytometry to a transmembrane type of αKl (data
not shown), indicating that both antibodies specifically recognize a tertiary protein structure
of an extracellular domain of αKl.
Sandwich ELISA for the detection of sαKl in human sera
A typical standard curve is shown in Fig.1A of the purified recombinant human sαKl protein
concentration between 94 pg/mL and 6000 pg/mL. The intra- and inter-assay coefficients of
variation (CV) were calculated by measuring three different doses with purified human sαKl
protein. As shown in Table S1A and S1B, both CVs ranged from 2.7 to 9.8%. The accuracy
of this assay in the presence of human serum and plasma was determined by serially diluting
recombinant human sαKl in 50% human serum and plasma. The measured sαKl levels were
then compared with theoretical sαKl levels contributed by the addition of recombinant sαKl
and the endogenous sαKl in serum and plasma. As shown in Table S1C, measured sαKl
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levels were 92.6% (in serum) and 94.1% (in plasma) of expected values. Furthermore, the
serum dose-response curves were parallel to the purified recombinant sαKl dose-response
curves (data not shown). Moreover, addition of recombinant human purified FGF23
(1μg/mL) did not affect a measurement (data not shown). Serum samples subjected to quick
freezing at −80°C and thawing at RT did not show a significant decrease during three cycles
(data not shown). These results indicate that sαKl can be measured with acceptable accuracy
in the presence of 50% human serum or plasma.
Immunoprecipitation of plasma sαKl protein from healthy subjects
To address whether both antibodies bind to the endogenous sαKl in human plasma as well
as the recombinant extracellular (soluble) αKl, immunoprecipitation was performed. Both
67G3 and 91F1 antibodies immunoprecipitated sαKl from plasma from healthy adult
subjects (Fig.1B) as well as the recombinant human sαKl (rhsαKl). Furthermore, the
densities of the immunopositive bands for precipitated sαKl (about 130kDa) precisely
corresponded to the concentrations of sαKl represented by ELISA (rhsαKl: 5000 pg/mL,
plasma 1: 575 pg/mL and plasma 2: 1272 pg/mL). These data suggest that both capture and
detection antibodies can bind to endogenous sαKl in blood, indicating that our sandwich
ELISA system can specifically detect and accurately measure the circulating sαKl.
Circulating sαKl concentrations in healthy adults
In order to determine the reference range of serum sαKl and to address the correlation of
several mineral parameters with sαKl in healthy adults, we next analyzed serum levels of
sαKl and indices of mineral metabolism in 142 healthy adults (age 20 years old or over)
(Table 1). The serum sαKl concentrations of healthy adults ranged from 239 to 1266 pg/mL
(mean ± SD; 562 ± 146 pg/mL). There was no apparent correlation of sαKl levels with
gender, iPTH, 1,25(OH)2D, calcitonin, Ca, Pi, BUN, Cre or FGF23 by simple regression
analyses. However, sαKl levels were slightly, but significantly correlated with age
(r=-0.199, P=0.017) and Cre (r=-0.183, P=0.030) by simple regression analyses.
Circulating sαKl concentrations in healthy children
As mineral metabolism dramatically changes in childhood, we compared concentrations of
sαKl between adults and children (<17 years) (Table 1). As expected, all factors measured
in this study (Ca, Pi, Cre, BUN and FGF23) were significantly different between adults and
children. The serum sαKl concentrations of normal children were significantly higher than
those of adults (mean ± SD; 952 ± 282 pg/mL in children vs 562±146 pg/mL in adults,
student's t-test, P<0.001, Fig.2A), indicating that serum sαKl correlated with age. The extent
of correlation of sαKl with other serum factors examined by simple regression analysis was
shown in Fig.2B-F. SαKl levels were found to correlate considerably with Pi (Fig.2C
r=0.517, P<0.001), Cre (Fig.2E, r=−0.538, P<0.001) and FGF23 (Fig.2F r=−0.350,
P<0.001) concentrations as well as age (Fig2B, r=−0.599, P<0.001). In addition, sαKl levels
also slightly, but significantly, correlated with BUN (Fig.2D, r=−0.203, P=0.006) but sαKl
levels did not significantly correlate with calcium.
Next, factors independently associated with serum sαKl levels were examined using a
multiple regression model. Serum sαKl exhibited significant and independent associations
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with age (P<0.001), Ca (P=0.004) and Pi (P=0.001), but no significant associations with
BUN (P=0.411), Cre (P=0.051), or FGF23 (P=0.089) as shown in Table S2. Pi was
positively correlated with sαKl. Interestingly, Ca and age were negatively correlated with
sαKl in this model, while Ca was a not significant factor with sαKl by simple regression
analysis.
Examination of sαKl levels in a patient with a αKl mutation
Ichikawa et al. have recently reported a case of hyperphosphatemic tumoral calcinosis with
hypervitaminosis D due to missense mutations in human α-klotho gene (a single amino acid
substitution from histidine193 to arginine). The authors concluded that, at least in part,
disruption of the architecture of αKl protein results in a failure to translocate to the plasma
membrane [16]. Consequently the subject's sαKl level was expected to be low. To test this
prediction, we measured serum from the patient and found that the serum sαKl level was
337 pg/mL. Because the patient was 14 years old, we prepared serum from age-matched
controls (n=11, mean ±SD: 13.5±1.7 years from 11.2 to 16.6 years old). As shown in Fig.
2G, sαKl levels of age-matched controls ranged from 652 to 1146 pg/mL, and these values
all fit within the mean value ± 2SD. As anticipated, the subject with α-Klotho mutation had
low concentrations of sαKl compared with age-matched controls.
Discussion
We developed an ELISA to successfully measure sαKl in human subjects and demonstrated
positive relationships with phosphorus, and negative relationships with age and Ca2+ in
multiple linear regression analysis. Since low calcium stimuli induce αKl secretion [5], the
negative relationship appears compatible. We have previously proposed a novel negative
feedback system involving FGF23 and αKl for maintenance of normal phosphate and
1,25(OH)2D levels [16,13]. Based on the fact that FGF23 is a negative regulator of
phosphate concentration (high FGF23 suppresses phosphate reabsorption in kidney), FGF23
correlates with phosphate in a positive manner (high phosphate induces high FGF23 level).
Predictably, sαKl correlates negatively with FGF23, but positively with phosphate in simple
regression analysis. We have proposed a mineral homeostatic system integrated by αKl,
where Ca2+ and PTH levels are acutely regulated by Na+,K+-ATPase activity [5] and
phosphate and 1,25(OH)2D levels are suppressed by FGF23 signals at late phase [8]. In this
system, FGF23 signals lead to the suppression of α-klotho gene expression and the
decreased synthesis of 1,25(OH)2D, an enhancer of α-klotho gene expression. A negative
correlation between sαKl and FGF23 levels could reflect this putative feedback system.
FGF23 concentrations are maintained at a low or normal level regardless of high phosphate
concentrations in children (Fig.S1). Since high phosphate has been reported to induce high
FGF23, low or normal FGF23 concentrations in children seem to be paradoxical. Although
the mechanism is unknown, this is postulated to be related to a higher need for adequate
bone mineralization during childhood. In contrast, sαKl is maintained at a high
concentration in children. Based on the preceding statistics that sαKl correlates positively
with phosphate, the high value of sαKl is not inconsistent with a high phosphate level even
at a young age. The balance of mineral metabolism in children is different from that in
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adults. It is very likely that a shift of metabolic equilibrium sustains higher phosphate
concentration and optimizes Ca2+ reabsorption in tubules. Further studies are required to
delineate the mechanism.
The manifestations seen in the patient with the α-klotho gene mutation resembled features
observed in α-klotho ablated mice, although the patient's phenotype was milder than that
observed in the mouse model. In an attempt to understand the manifestations seen in this
patient, we verified sαKl levels using the ELISA system. Since the mutated protein impairs
the intracellular trafficking ability in vitro, the sαKl level of the patient was expected to be
low. Indeed, the sαKl value was more than 50% lower than the mean value of healthy age-
matched subjects. Accordingly, the ELISA may be useful in studying disorders of mineral
metabolism.
SαKl levels are higher in adolescence and lower in older adults and negatively correlate
with Cre and BUN, which are increased in an age-dependent fashion even in healthy
humans. Therefore, sαKl concentrations in serum are expected to be noted as a biomarker
for kidney function. In the present study, we are not able to analyze the effect of renal
function on sαKl and vice versa, since our subjects had normal renal function. Notably, in
renal failure, α-klotho mRNA expression is decreased [18], though this may be due to death
of the cells in the nephron expressing αKl. Further study is necessary to determine the utility
of this ELISA in renal failure.
Kurosu et al reported that an increase of sαKl levels by genetic manipulation of full-length
α-Klotho resulted in a prolonged life span in mice [19]. In that paper, since the levels of
normal sαKl in mice were measured at >10ng/ml by radioimmunoassay [19], they were
estimated to be approximately 20 fold greater than the average normal human sαKl
concentration in this study. However, as previously reported, murine sαKl levels were
calculated to be similar to that of humans by immunoprecipitation followed by western blot
analysis [6]. These findings indicate that serum sαKl concentration should be carefully
estimated to evaluate the roles of sαKl level in life span elongation. In addition, whereas two
to three-fold elevations in sαKl level were noted in longevity-elongated mice [19], this
magnitude would be within the divergence seen in healthy human subjects. Furthermore,
this cross-sectioned study identified that younger subjects have higher sαKl, and that older
subjects (who have lived longer) have lower sαKl. Therefore, careful prospective
longitudinal studies would be needed to determine whether future longevity can be
predictable from sαKl concentrations at one point in time.
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Enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation analysis by two
useful anti-sαKl monoclonal antibodies. (A) Typical dose-response curve of recombinant
human sαKl (rhsαKl). Sandwich ELISA for sαKl was performed by 67G3 as a capture
antibody and 91F1 as a detection antibody. The results are expressed as the mean ± standard
deviation (SD) of triplicate measurements. (B) Immunoprecipitation of plasma sαKl by
67G3 and 91F1 antibodies. Conditioned medium from CHO cells stably expressing FGF23
(rhsαKl) and plasma from healthy volunteers (plasma 1, plasma 2) were immunoprecipitated
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anti-Klotho antibodies (67G3 and 91F1) and control mouse IgG1 (cont. Ab.), and analyzed
by Western blot with anti-human Klotho rabbit polyclonal antibodies, N116 and C939.
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Serum sαKl levels (A) Comparison of serum sαKl levels between healthy adults and
children. Serum sαKl levels of healthy adults (n=142, age: >20 years) and children (n=39,
age: <17years) were measured. Results represent mean ± standard deviation (SD). Statistical
analysis was performed by student's t-test. P values less than 0.05 were taken as statistically
significant. Correlation of serum sαKl with (B) age (C) Pi (D) BUN (E) Cre and (F) FGF23
levels in simple regression analysis in healthy subjects. The open circles and triangles
represent male and female subjects, respectively. Statistical analysis was performed by
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Pearson correlation. P values less than 0.05 were taken as statistically significant. (G)
Comparison of serum sαKl levels between a patient with klotho missense mutation and age-
matched healthy subjects. Serum sαKl levels from 11 healthy subjects (left, age: from 11.2
to 16.6 years) and a patient with klotho homozygous gene mutation (right, age: 14 years)
were shown. An error bar along the values for healthy controls represents mean ± 2 fold of
standard deviation (2SD) in order to indicate a reference range.
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Table 1
Yamazaki Y et al
number: total (male/female) all 181 (89/92) children (<17yrs) 39 (23/16) adults (>20yrs) 142 (66/76) P children vs adults
Age year 49.4 ± 27.7 7.1 ± 4.8 61.1 ± 18.5 <0.001
Ca mg/dL 9.50 ± 0.44 9.65 ± 0.52 9.46 ± 0.41 0.018
Pi mg/dL 3.90 ± 0.75 4.88 ± 0.68 3.63 ± 0.51 <0.001
Ca x Pi (mg/dL)2 37.1 ± 8.0 47.2 ± 7.9 34.4 ± 5.3 <0.001
BUN mg/dL 15.2 ± 4.3 13.3 ± 3.6 15.7 ± 4.3 0.002
Cre mg/dL 0.62 ± 0.19 0.36 ± 0.12 0.69 ± 0.14 <0.001
Alb mg/dL 4315 ± 384 4190 ± 474 4349 ± 349 0.021
1,25(OH)2D pg/mL ND ND 54.8 ± 17.7 ND
iPTH pg/mL ND ND 49.2 ± 20.6 ND
calcitonin pg/mL ND ND 26.0 ± 12.3 ND
FGF23 pg/mL 39.6 ± 18.4 24.2 ± 12.0 43.8 ± 17.6 <0.001
ND: not determined
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